LOXL۲ silencing suppresses angiotensin II-induced cardiac hypertrophy through the EMT process and TGF-β۱/Smad۳/NF-κB pathway

  • سال انتشار: 1401
  • محل انتشار: مجله علوم پایه پزشکی ایران، دوره: 25، شماره: 8
  • کد COI اختصاصی: JR_IJBMS-25-8_005
  • زبان مقاله: انگلیسی
  • تعداد مشاهده: 129
دانلود فایل این مقاله

نویسندگان

Jun Luo

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Yingbiao Wu

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Xi Zhu

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Saihua Wang

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Xiaogang Zhang

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

Zhongping Ning

Department of Cardiology, Shanghai University of Medicine & Health Sciences affiliated Zhoupu Hospital, Shanghai ۲۰۱۳۱۸, China

چکیده

Objective(s): Atrial fibrillation (AF) is a common arrhythmia with atrial myocyte hypertrophy linked with stroke, heart failure, and increased mortality. Lysyl oxidase-like ۲ (LOXL۲) involves the cross-linking of collagen in the extracellular matrix (ECM). In the present study, we investigated the roles and underlying mechanisms of LOXL۲ on cardiomyocyte hypertrophy. Materials and Methods: The expression of LOXL۲ mRNA and protein were detected in angiotensin II (Ang II) treated rat cardiomyocytes H۹c۲ by RT-qPCR and western blot. Small interfering RNA (siRNA) mediated LOXL۲ gene silencing was used to evaluate cardiac hypertrophy and related markers. Also, the protein expression of EMT markers and Smad۳/NF-κB pathway was determined by western blot. Results: Ang II significantly increased mRNA and protein expressions of LOXL۲ and increased mRNA levels of myocardial hypertrophy markers, including ANP, BNP, and β-MHC in H۹c۲ cells. Silencing of LOXL۲ significantly suppressed Ang II-induced hypertrophy and reversed the increase in ANP, BNP, and β-MHC mRNA levels. Also, EMT markers’ expressions, as evidenced by increased E-cadherin and decreased vimentin, α-smooth muscle actin (α-SMA), fibroblast-specific protein (FSP), and collagen ۱A۱. Mechanistically, we found that LOXL۲ silencing suppressed protein expressions of TGF-β۱, p-Smad۳, and p-NF-κB in Ang II-stimulated H۹c۲ cells. LOXL۲ silencing also attenuated Ang II-induced increased expression and content of proinflammatory cytokines IL-۱β (H) and TNF-α. Conclusion: Our data speculated that LOXL۲ might be a potential contributing factor to Ang II-induced cardiac hypertrophy, and TGF-β۱/Smad۳/NF-κB is involved in a signal axis and might be a potential strategy in treating cardiac hypertrophy. 

کلیدواژه ها

Angiotensin II, Atrial fibrillation, Epithelial-mesenchymal - transition, Hypertrophy, LOXL۲ protein

اطلاعات بیشتر در مورد COI

COI مخفف عبارت CIVILICA Object Identifier به معنی شناسه سیویلیکا برای اسناد است. COI کدی است که مطابق محل انتشار، به مقالات کنفرانسها و ژورنالهای داخل کشور به هنگام نمایه سازی بر روی پایگاه استنادی سیویلیکا اختصاص می یابد.

کد COI به مفهوم کد ملی اسناد نمایه شده در سیویلیکا است و کدی یکتا و ثابت است و به همین دلیل همواره قابلیت استناد و پیگیری دارد.